178 related articles for article (PubMed ID: 28934165)
21. Differential Killing of Salmonella enterica Serovar Typhi by Antibodies Targeting Vi and Lipopolysaccharide O:9 Antigen.
Hart PJ; O'Shaughnessy CM; Siggins MK; Bobat S; Kingsley RA; Goulding DA; Crump JA; Reyburn H; Micoli F; Dougan G; Cunningham AF; MacLennan CA
PLoS One; 2016; 11(1):e0145945. PubMed ID: 26741681
[TBL] [Abstract][Full Text] [Related]
22. Growth-phase regulation of lipopolysaccharide O-antigen chain length influences serum resistance in serovars of Salmonella.
Bravo D; Silva C; Carter JA; Hoare A; Álvarez SA; Blondel CJ; Zaldívar M; Valvano MA; Contreras I
J Med Microbiol; 2008 Aug; 57(Pt 8):938-946. PubMed ID: 18628492
[TBL] [Abstract][Full Text] [Related]
23. Complement factor C3 deposition and serum resistance in isogenic capsule and lipooligosaccharide sialic acid mutants of serogroup B Neisseria meningitidis.
Vogel U; Weinberger A; Frank R; Müller A; Köhl J; Atkinson JP; Frosch M
Infect Immun; 1997 Oct; 65(10):4022-9. PubMed ID: 9317002
[TBL] [Abstract][Full Text] [Related]
24. Sialylation of Porphyromonas gingivalis LPS and its effect on bacterial-host interactions.
Zaric SS; Lappin MJ; Fulton CR; Lundy FT; Coulter WA; Irwin CR
Innate Immun; 2017 Apr; 23(3):319-326. PubMed ID: 28205451
[TBL] [Abstract][Full Text] [Related]
25. Complement activation by Proteus mirabilis negatively charged lipopolysaccharides.
Kaca W; Literacka E; Sjöholm AG; Weintraub A
J Endotoxin Res; 2000; 6(3):223-34. PubMed ID: 11052177
[TBL] [Abstract][Full Text] [Related]
26. Human complement activation by smooth and rough Proteus mirabilis lipopolysaccharides.
Kaca W; Arabski M; Fudała R; Holmström E; Sjöholm A; Weintraub A; Futoma-Kołoch B; Bugla-Płoskońska G; Doroszkiewicz W
Arch Immunol Ther Exp (Warsz); 2009; 57(5):383-91. PubMed ID: 19707721
[TBL] [Abstract][Full Text] [Related]
27. Systems Biology and Pangenome of
Seif Y; Monk JM; Machado H; Kavvas E; Palsson BO
mBio; 2019 Aug; 10(4):. PubMed ID: 31455646
[TBL] [Abstract][Full Text] [Related]
28. A quantitative analysis of C3 binding to O-antigen capsule, lipopolysaccharide, and outer membrane protein of E. coli 0111B4.
Joiner KA; Goldman R; Schmetz M; Berger M; Hammer CH; Frank MM; Leive L
J Immunol; 1984 Jan; 132(1):369-75. PubMed ID: 6197449
[TBL] [Abstract][Full Text] [Related]
29. Complement activation via the alternative pathway by purified Salmonella lipopolysaccharide is affected by its structure but not its O-antigen length.
Grossman N; Leive L
J Immunol; 1984 Jan; 132(1):376-85. PubMed ID: 6197450
[TBL] [Abstract][Full Text] [Related]
30. The O-Antigen Capsule of Salmonella enterica Serovar Typhimurium Facilitates Serum Resistance and Surface Expression of FliC.
Marshall JM; Gunn JS
Infect Immun; 2015 Oct; 83(10):3946-59. PubMed ID: 26195553
[TBL] [Abstract][Full Text] [Related]
31. O-antigen delays lipopolysaccharide recognition and impairs antibacterial host defense in murine intestinal epithelial cells.
Duerr CU; Zenk SF; Chassin C; Pott J; Gütle D; Hensel M; Hornef MW
PLoS Pathog; 2009 Sep; 5(9):e1000567. PubMed ID: 19730692
[TBL] [Abstract][Full Text] [Related]
32. Altering the length of the lipopolysaccharide O antigen has an impact on the interaction of Salmonella enterica serovar Typhimurium with macrophages and complement.
Murray GL; Attridge SR; Morona R
J Bacteriol; 2006 Apr; 188(7):2735-9. PubMed ID: 16547065
[TBL] [Abstract][Full Text] [Related]
33. [Bactericidal activity of normal human serum to gram-negative rods with sialic acid containing lipopolysaccharide].
Bugla G; Doroszkiewicz W; Gamian A; Korzeniowska-Kowal A
Med Dosw Mikrobiol; 2004; 56(3):255-61. PubMed ID: 15773502
[TBL] [Abstract][Full Text] [Related]
34. The factor C3 conversion in human complement by smooth Shigella flexneri lipopolysaccharides.
Fudała R; Doroszkiewicz W; Niedbach J; Gamian A; Weintraub A; Kaca W
Acta Microbiol Pol; 2003; 52(1):45-52. PubMed ID: 12916727
[TBL] [Abstract][Full Text] [Related]
35. Role of YadA, Ail, and Lipopolysaccharide in Serum Resistance of Yersinia enterocolitica Serotype O:3.
Biedzka-Sarek M; Venho R; Skurnik M
Infect Immun; 2005 Apr; 73(4):2232-44. PubMed ID: 15784567
[TBL] [Abstract][Full Text] [Related]
36. Evasion of complement-mediated lysis and complement C3 deposition are regulated by Francisella tularensis lipopolysaccharide O antigen.
Clay CD; Soni S; Gunn JS; Schlesinger LS
J Immunol; 2008 Oct; 181(8):5568-78. PubMed ID: 18832715
[TBL] [Abstract][Full Text] [Related]
37. Structure of the LPS O-chain from Fusobacterium nucleatum strain 10953, containing sialic acid.
Vinogradov E; St Michael F; Homma K; Sharma A; Cox AD
Carbohydr Res; 2017 Feb; 440-441():38-42. PubMed ID: 28199859
[TBL] [Abstract][Full Text] [Related]
38. [Lipopolysaccharides containing sialic acid].
Gamian A
Postepy Hig Med Dosw; 1996; 50(5):459-72. PubMed ID: 9072762
[TBL] [Abstract][Full Text] [Related]
39. Purification of antibodies to O antigen of Salmonella Typhimurium from human serum by affinity chromatography.
O'Shaughnessy CM; Micoli F; Gavini M; Goodall M; Cobbold M; Saul A; Maclennan CA
J Immunol Methods; 2013 Jan; 387(1-2):199-210. PubMed ID: 23142459
[TBL] [Abstract][Full Text] [Related]
40. Biological functions of sialic acid as a component of bacterial endotoxin.
Dudek B; Rybka J; Bugla-Płoskońska G; Korzeniowska-Kowal A; Futoma-Kołoch B; Pawlak A; Gamian A
Front Microbiol; 2022; 13():1028796. PubMed ID: 36338080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
